Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05812430
Status:
RECRUITING
Last Update Posted:
2023-09-13
First Post:
2023-03-13
Brief Title:
Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer
Sponsor:
Organization:
The First Affiliated Hospital of Zhengzhou University